Safe enough for whom? Regulation in thin device markets

Device regulation sounds like paperwork until you see both of its absences at once. Where regulation is thin, needed equipment clears borders fast — and so does equipment with no business near a patient: the uncertified, the counterfeit, the long-recalled riding a resale market into its third continent.

WHO's global surveys of health technology have long documented how unevenly device regulation is distributed; many countries lack the regulatory capacity that high-income markets take for granted, and reliance on foreign approvals (a CE mark, an FDA clearance) becomes the de facto national standard — workable, but blind to context and to what happens after import.

For hospitals and networks operating in thin-regulation environments, the practical move is private diligence: verify certifications genuinely exist, check recall databases before accepting older models, insist on provenance for refurbished gear, and treat 'too cheap to be true' with clinical suspicion. None of this replaces public regulation — it bridges toward it.

Regulation done well is not friction; it's the immune system of a device market. Supporting countries building that capacity — as WHO and partners work to do — protects every storeroom and ward downstream. In the meantime, networks that share diligence findings give small hospitals a fraction of the protection big systems buy with staff.